Vestal Point Capital »

Belite Bio shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $23M 313k 74.00

More positions owned by Vestal Point Capital

Ascendis Pharma A/S Sponsored Adr (ASND)
Arcellx Common Stock (ACLX)
Nuvalent Inc-a (NUVL)
Abivax SA Sponsored Ads (ABVX)
Alcon Ord Shs (ALC)
Bicara Therapeutics (BCAX)
Amicus Therapeutics (FOLD)
Globus Medical Cl A (GMED)
Ionis Pharmaceuticals (IONS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Becton, Dickinson and (BDX)
Scholar Rock Hldg Corp (SRRK)
Immatics NV SHS (IMTX)
Repligen Corporation (RGEN)
Dianthus Therapeutics (DNTH)

View all positions for Vestal Point Capital

Top funds holding Belite Bio

RA Capital Management
Rtw Investments
Vestal Point Capital
Soleus Capital Management
Eventide Asset Management
Marshall Wace
UBS Group
Perceptive Advisors
Millennium Management
Geode Capital Management
State Street Corporation
Bnp Paribas Arbitrage, Snc
Citadel Advisors
Jpmorgan Chase & Co
Polymer Capital Management

View all funds holding Belite Bio